Status:
COMPLETED
Bioequivalence Study of V0057 Versus a Reference Formulation After Single Administration in Healthy Male Subjects
Lead Sponsor:
Pierre Fabre Dermatology
Conditions:
Healthy Volunteers
Eligibility:
MALE
18-50 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the bioequivalence (comparison of the rate and extent of the active substance into the body following single administration of the drugs) between the test prod...
Eligibility Criteria
Inclusion
- Healthy male subject aged 18 to 50 years (inclusive)
Exclusion
- Presence of any significant medical finding or significant history that may impact the safety, the interpretation of the results and/or the participation of the subject in the study according to the opinion of the investigator
- Presence of any clinically significant abnormal finding at examination in the Investigator's opinion
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT01861626
Start Date
May 1 2013
End Date
June 1 2013
Last Update
June 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erfurt, Germany, D-99084